We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Microbiologics and Microbix Partner on Viral Controls for Diagnostics

By LabMedica International staff writers
Posted on 12 Apr 2015
Print article
Image: Under a new partnership, inactivated viruses from Microbix Biosystems, Inc. will be incorporated into a line of full process controls under Microbiologics’ Helix Elite Molecular Standards brand as well as instrument-specific quality control sets (Photo courtesy of Microbiologics).
Image: Under a new partnership, inactivated viruses from Microbix Biosystems, Inc. will be incorporated into a line of full process controls under Microbiologics’ Helix Elite Molecular Standards brand as well as instrument-specific quality control sets (Photo courtesy of Microbiologics).
Microbiologics, Inc. (St. Cloud, MN, USA) has entered into an agreement to source inactivated viruses from Microbix Biosystems, Inc. (Mississauga, ON, Canada) to be incorporated into a line of full process controls under Microbiologics’ Helix Elite Molecular Standards brand as well as instrument-specific quality control sets.

Diagnostic assays are dependent on controls to demonstrate test performance characteristics and staff proficiency, but laboratories struggle to identify adequate biomaterials and frequently use clinical samples that may not be well characterized or consistently available. Increased regulation requires that labs more carefully consider the source, quality, and format of their molecular and culture-based control materials. This partnership will combine both companies’ expertise in biomaterial development, preservation, and distribution to create highly stable viral controls for molecular testing.

“We are pleased to use Microbix materials in Microbiologics products as they have a strong, global reputation for high-quality viral preparations for the vaccine and immunodiagnostics markets” Brian Beck, PhD, vice president, Molecular Products and Services, Microbiologics, “Incorporation of Microbix viral materials into our lyophilized, molecular-compatible formats complements our existing synthetic standards and extends our catalog to include extraction controls for gastrointestinal, respiratory, blood borne, and sexually transmitted viral pathogens.”

Phil Casselli, senior vice president, Business Development, Microbix, said, “We are pursuing a multipronged approach to exploit the high-growth molecular diagnostics marketplace. Microbiologics has relationships with instrument manufacturers, as well as large-scale distribution capabilities, making them an ideal partner to help expand the reach of our developing molecular program. Our unique isolates offering complements Microbiologics’ strengths. We will both be focused on what we do best in this relationship.”

“As part of our commitment to a safer, healthier world, Microbiologics continues to partner with industry leaders such as Microbix to develop advanced, practical controls that support the evolving field of molecular microbiology,” said Brad Goskowicz, Microbiologics’ CEO, “We look forward to working with molecular diagnostic manufacturers to ensure that clinical laboratories have the appropriate and highest quality control material for their instruments and assays.”

Related Links:
Microbiologics
Microbix Biosystems
Helix Elite, CE-marked IVD molecular standards

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.